OFIX Stock Overview
Operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Orthofix Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$18.87 |
| 52 Week High | US$20.73 |
| 52 Week Low | US$10.28 |
| Beta | 1.05 |
| 11 Month Change | 16.48% |
| 3 Month Change | 13.27% |
| 1 Year Change | 66.55% |
| 33 Year Change | -42.50% |
| 5 Year Change | -58.25% |
| Change since IPO | 79.71% |
Recent News & Updates
Shareholder Returns
| OFIX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.2% | -0.4% | -1.0% |
| 1Y | 66.5% | 20.3% | 30.3% |
Return vs Industry: OFIX exceeded the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: OFIX exceeded the US Market which returned 30.4% over the past year.
Price Volatility
| OFIX volatility | |
|---|---|
| OFIX Average Weekly Movement | 5.4% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: OFIX has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: OFIX's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 1,634 | Massimo Calafiore | www.orthofix.com |
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.
Orthofix Medical Inc. Fundamentals Summary
| OFIX fundamental statistics | |
|---|---|
| Market cap | US$715.75m |
| Earnings (TTM) | -US$119.02m |
| Revenue (TTM) | US$784.25m |
0.9x
P/S Ratio-6.1x
P/E RatioIs OFIX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OFIX income statement (TTM) | |
|---|---|
| Revenue | US$784.25m |
| Cost of Revenue | US$228.40m |
| Gross Profit | US$555.85m |
| Other Expenses | US$674.88m |
| Earnings | -US$119.02m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.11 |
| Gross Margin | 70.88% |
| Net Profit Margin | -15.18% |
| Debt/Equity Ratio | 22.5% |
How did OFIX perform over the long term?
See historical performance and comparison